Dashboard
Manage Tickers

LEXX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
09/02/2024 16:30:57

Core News & Articles
Lexaria Bioscience Announces Tolerability ...
08/29/2024 13:36:37

Absorption improvements appear to continue with DehydraTECH-processed Rybelsus® vs. Rybelsus® tablets even under "fed" ...

lexaria-bioscience-announces-initial-results-from-glp-1-human-pilot-study-showing-trend-toward-higher-absorption-of-dehydratech-processed-rybelsus-compared-to-unprocessed-version-under-fed-conditions
Lexaria Bioscience Announces Initial Resul...
08/27/2024 13:24:20

lexaria-bioscience-announces-results-from-research-collaboration-with-national-research-council-of-canada-demonstrating-dehydratechs-ability-to-preserve-monomeric-form-of-glp-1-drug-semaglutide
Lexaria Bioscience Announces Results From ...
08/19/2024 13:08:01

hc-wainwright--co-reiterates-buy-on-lexaria-bioscience-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Lexa...
07/18/2024 16:40:28

HC Wainwright & Co. analyst Yi Chen reiterates Lexaria Bioscience (NASDAQ:LEXX) with a Buy and maintains $10 price target.

interim-body-weight-results-from-lexarias-diabetes-animal-study-says-dehydratech-appears-to-work-with-a-second-glp-1-drug-liraglutide-dehydratech-cbd-is-showing-strong-apparent-performance-relative-to-glp-1-appears-to-be-working-with-semaglutide-both-with-and-without-snac-technology
Interim Body Weight Results From Lexaria's...
07/17/2024 14:37:39

- Reuters 

Core News & Articles
Lexaria Preparing For Strategic Growth, Ex...
07/16/2024 13:30:09

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug d...

lexaria-bioscience-q3-eps-013-misses-010-estimate-sales-8400k-miss-15000k-estimate
Lexaria Bioscience Q3 EPS $(0.13) Misses $...
07/12/2024 18:07:08

Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of ...

hc-wainwright--co-initiates-coverage-on-lexaria-bioscience-with-buy-rating-announces-price-target-of-10
HC Wainwright & Co. Initiates Coverage On ...
07/10/2024 10:48:03

HC Wainwright & Co. analyst Yi Chen initiates coverage on Lexaria Bioscience (NASDAQ:LEXX) with a Buy rating and announc...

Core News & Articles
Lexaria Receives 3 New Patents For Antivir...
07/08/2024 13:20:09

Lexaria currently holding 46 granted patents worldwideKELOWNA, BC / ACCESSWIRE / July 8, 2024 / Lexaria Bioscience Corp. (NASDA...

lexaria-bioscience-hires-cro-to-oversee-12-week-study-on-dehydratech-glp-1-formulations-major-objectives-include-weight-loss-and-blood-sugar-reduction
Lexaria Bioscience Hires CRO To Oversee 12...
06/18/2024 13:06:53

lexaria-bioscience-announces-progress-in-human-pilot-study-glp-1-h24-2-second-round-of-dosing-completed-for-all-nine-participants-final-arm-expected-to-finish-by-early-july
Lexaria Bioscience Announces Progress In H...
06/05/2024 13:07:16

why-healthequity-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why HealthEquity Shares Are Trading Higher...
06/04/2024 09:50:06

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/30/2024 16:31:20

Core News & Articles
Lexaria Awards Contract To A CRO To Perfor...
05/23/2024 14:56:55

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKELOWNA, BC / ACCESSWIRE / M...

lexaria-granted-patent-21-compositions-and-methods-for-treating-hypertension-and-24-compositions-and-methods-for-treating-epilepsy
Lexaria Granted Patent #21: Compositions a...
05/21/2024 13:32:32

lexaria-bioscience-begins-dosing-in-glp-1-animal-study
Lexaria Bioscience Begins Dosing In GLP-1 ...
05/17/2024 13:12:19

Core News & Articles
Lexaria Announces New Research Program To ...
05/06/2024 13:08:30

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug d...

Core News & Articles
Lexaria To Receive $4.7M Gross Proceeds In...
04/30/2024 19:53:35

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug d...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/16/2024 20:31:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION